Replies to post #345670 on Innovation Pharmaceuticals Inc (IPIX)

[stevo99]

Looks like the real world to me

" Brilacidin has already been successfully tested in clinical trials and shown to exhibit potent antibacterial activity in Phase 2 clinical trials for treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI), and anti-inflammatory activity, as supported in Phase 2 clinical trials for treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis. As such, brilacidin has already demonstrated HDP-like therapeutic properties in the clinic."

[LIVED]

There's a second part to this equation that I'll let others figure out.

Does the second part state that these have different mechanisms of action?